Download Free Medical Nuclear Cardiology-Basics PowerPoint Presentation

Nuclear Cardiology-Basics PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : Check out this medical PowerPoint presentation titled "NUCLEAR CARDIOLOGY- BASICS” by Dr. THIRUMURTHI.

This medical PowerPoint presentation is about nuclear cardiology, a medical specialty that involves the use of radioactive materials to diagnose and treat heart disease. It is a type of imaging technique that combines nuclear medicine and cardiology to provide detailed images of the heart and its blood vessels.

The most common nuclear cardiology test is the myocardial perfusion imaging (MPI) scan, which uses a small amount of a radioactive substance injected into the patients bloodstream. The radioactive material then travels to the heart, and a special camera is used to take images of the heart as it pumps blood. These images can show areas of the heart that may not be receiving enough blood flow, which can indicate the presence of heart disease.

Another nuclear cardiology test is the positron emission tomography (PET) scan, which also uses a radioactive tracer to produce detailed images of the heart. PET scans are often used to assess the effectiveness of treatments for heart disease and to monitor patients with heart conditions.

Nuclear cardiology is a safe and effective way to diagnose and manage heart disease. However, as with any medical procedure, there are risks associated with the use of radioactive materials. Patients should discuss the benefits and risks of nuclear cardiology with their healthcare provider before undergoing any tests or treatments.

Tags : nuclear cardiology, heart disease, imaging technique, Nuclear Medicine, Nuclear Medicine PowerPoint presentation

Published on : Jun 20, 2023 | Views : 859 | Downloads : 1

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

NUCLEAR CARDIOLOGY- BASICS Dr. THIRUMURTHI CHIEF-NUCLEAR MEDICINE MADRAS MEDICAL MISSION
Slide 2-

Nuclear Medicine Specialty in which a wide range of clinical conditions are investigated using radioactive tracers administered to the patient It is completely different process from X-Ray, CT and MRI scan (these look at the anatomy of the body) To look at the function of the body, Nuclear Medicine uses gamma rays
Slide 3-

Nuclear Medicine Gamma rays are very similar to X-Rays, but the major difference is that the gamma rays are emitted by pharmaceuticals injected into the bloodstream rather than being produced by machines outside the body. Gamma rays are detected by the gamma camera
Slide 4-

Gamma Rays (from Doe Medical Sciences webpage)
Slide 5-

Myocardial Perfusion Imaging Radiopharmaceuticals : 201Thallium Technetium based agents PET * Ammonia
Slide 6-

Technetium based agents 99m Technetium T 1/2 - 6 Hrs Pharmaceuticals : SestaMIBI, Tetrofosmin SestaMIBI: Methoxy Iso Butyl Isonitrile Passive diffusion Uptake proportional to blood flow & no redistribution Good quality images, gating, easy availability & Cost effective
Slide 7-

© Continuing Medical Implementation …...bridging the care gap Exercise stress testing Treadmill or bicycle ergometer Protocols vary - symptom limited Bruce most popular 8 stages Incline and speed increment every 3 minutes Target 85-100% maximum age predicted HR Achieve at least 6 METS for diagnostic accuracy
Slide 8-

MPI Stress Procedure Treadmill Pharmacological stress IV Dobutamine / Adenosine DOBUTAMINE Max.Dosage: 40 ug / kg / min + Inj.Atropine 0.6 mg IV ADENOSINE Dose : 140 ug / kg / min - 6 min
Slide 9-

Indications Screening of IHD Physiological significance of lesions post CAG Post PTCA & post CABG evaluation Risk stratification Myocardial viability detection
Slide 10-

Diagnostic Accuracy 1. O’Rourke RA, et al. Circulation. 2000;102:126-140. 2. Wackers FJ, et al. Nuclear cardiology. In: Braunwald E, ed. Heart Disease: A Textbook of Cardiovascular Medicine. 5th ed. Philadelphia, Pa: WB Saunders; 1997. P r e d i c t i v e A c c u r a c y %Sensitivity %Specificity Exercise Stress ECG1 6 7 7 4 6 9 Exercise Stress Echo1 8 5 7 9 8 3 MPI1 8 9 80 8 9 %
Slide 11-

ppt slide no 11 content not found
Slide 12-

ppt slide no 12 content not found
Slide 13-

ppt slide no 13 content not found
Slide 14-

ppt slide no 14 content not found
Slide 15-

ppt slide no 15 content not found
Slide 16-

Flow tracers Rb-82 0-15 N-13 Tc-99m MIBI Tl-201
Slide 17-

Metabolic tracer F-18 – fluorodeoxyglucose(FDG) F-18 –BMS 747158 I-123 BMIPP
Slide 18-

ppt slide no 18 content not found
Slide 19-

ppt slide no 19 content not found
Slide 20-

Perfusion Metabolism Reversible Stunning Reversible Hibernation Irreversible Scar Dysfunction Condition
Slide 21-

MIBI & FDG 30% OF NO PERFUSION SEGMENT SHOWS FDG UPTAKE
Slide 22-

Influence of Viability Testing on Outcomes With Revascularization 3.2 16 7.7 6.2 0 4 8 12 16 20 Annual Cardiac Death Rate (%) Revasc Med Rx Revasc Med Rx Viable Non-viable -80% p<0.0001 p=NS (Allman, JACC 2002; 39: 1151-1158)
Slide 23-

ACC/AHA Recommendations for the Use of Radionuclide Techniques to Assess Myocardial Viability Class I: Conditions for which there is evidence and/or general agreement that a given procedure or treatment is useful and effective LOE B: Data derived from a single randomized trial, or from nonrandomized studies
Slide 24-

First-Pass Radionuclide Angiography(RNA)
Slide 25-

Indications Coronary artery disease (CAD) Valvular heart disease Congenital heart disease
Slide 26-

Equilibrium Gated Radionuclide Ventriculogram MUGA
Slide 27-

Purpose Examine the function of the pumping chambers of the heart Left ventricle measurements are more accurate than the right because of the heart’s anatomy (gated first-pass study with radionuclides that do not pass the lungs maybe used for the right ventricle)
Slide 28-

ppt slide no 28 content not found
Slide 29-

BPGS - Blood Pool Gated SPECT Analysis:
Slide 30-

ppt slide no 30 content not found
Slide 31-

ppt slide no 31 content not found
Slide 32-

ppt slide no 32 content not found
Slide 33-

ppt slide no 33 content not found
Slide 34-

Imaging CTPA is now the recommended initial lung imaging modality for non-massive PE. [B] Patients with a good quality negative CTPA do not require further investigation or treatment for PE. [A] Isotope lung scanning may be considered as the initial imaging investigation providing (a) facilities are available on site, and (b) chest radiograph is normal, and (c) there is no significant symptomatic concurrent cardiopulmonary disease, and (d) standardised reporting criteria are used, and (e) a non-diagnostic result is always followed by further imaging. [B]